Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tight RA Control Via Telemedicine Noninferior to Conventional Clinic Visits

Reuters Staff  |  June 12, 2017

NEW YORK (Reuters Health—Telemedicine follow up based on patient-reported outcome (PRO) is noninferior to conventional outpatient care for tight control of disease activity in rheumatoid arthritis (RA) patients with low disease activity or remission, new findings show.

“Even though patients in the [telemedicine] follow-up groups requested more acute visits, they over-all had a more than 50% reduction in face-to-face consultations,” Dr. Annette Thurah of Aarhus University Hospital in Denmark and colleagues write. “Hence, the tele-health follow up save(s) patient time and is likely to reduce healthcare costs.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The study was published online May 16 in Arthritis Care and Research.¹

The European League Against Rheumatism recommends monitoring as often as monthly for RA patients with high/moderate disease activity, and less often, for example every six months, in patients who have sustained low disease activity or who are in remission, Dr. Thurah and her team note.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

To investigate whether telemedicine monitoring could offer an alternative to clinic visits for follow-up, the researchers randomly assigned 294 RA patients treated at two outpatient clinics to receive PRO-based telemedicine follow up delivered by a nurse (PRO-TN) or a rheumatologist (PRO-TR), or standard outpatient care.

At Week 52, both PRO-TN and PRO-TR were noninferior based on change in Disease Activity Score 28. The PRO-TN and PRO-TR groups averaged 1.72 and 1.75 outpatient clinic visits, respectively, while the controls averaged 4.15 visits per year.

Over 80% of patients in each of the three groups reported being “very satisfied” with their care, and there were no differences in patient satisfaction among the groups.

Nineteen patients dropped out of the study, most of who were in the PRO-TN group, the authors note.

“We do not know if the fact that patients were contacted by a nurse and not a doctor prompted some to drop out, or if some patients dropped out because they felt generally insecure about attending [telemedicine] control,” they write. “The question is, however, of great importance to future implementation and thus, studies investigating the patients’ perspective on [telemedicine] interventions in RA are needed.”

Dr. Thurah was not available for an interview by press time.


Reference

  1. Thurah A, Stengaard-Pedersen K, Axelsen M, et al. A Tele-health Follow-up Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of the Non-inferiority Randomised Controlled Trail (the TeRA study). Arthritis Care Res (Hoboken). 2017 May 16. doi: 10.1002/acr.23280. [Epub ahead of print]

Share: 

Filed under:AppsResearch RheumTechnologyTechnology Tagged with:Arthritis Care & Researchoffice visitpatient careRheumatoid Arthritis (RA)Technologytelemedicine

Related Articles

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    Telemedicine & Fellowship Education After COVID-19: Q&A with Kanika Monga, MD

    July 14, 2020

    The COVID-19 pandemic is reshaping clinical rheumatology and the fellowship experience. Rheumatology education should include how to triage patients for remote visits, says second-year fellow Kanika Monga, MD…

    The ACR Releases New Telemedicine Position Statement

    July 6, 2020

    The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences